Healthcare Industry News: Kyphoplasty
News Release - October 16, 2012
STERIS Corporation and NeuroLogica Announce CollaborationCompanies to provide integrated intraoperative solutions
DANVERS, Mass.--(Healthcare Sales & Marketing Network)--STERIS Corporation (STE), a recognized leader in surgical support and integration technologies, and NeuroLogica Corp., designers and manufactures of portable imaging equipment, have formed a collaborative relationship to offer fully integrated, intraoperative surgical suites to healthcare systems. The goal of these joint efforts is to help healthcare providers expand their procedural capabilities, through improved workflow and cost-effective approaches for neurosurgical therapies.
These highly integrated surgical suites will include the technologies of both medical device leaders. NeuroLogica will provide BodyTom®, the first and only full-body, 32-slice, portable CT scanner on the market. With an 85cm gantry, 60cm field of view, portability, internal lead shielding and complete integration with the top names in surgical navigation and planning systems, BodyTom® is the ideal solution for a number of neurosurgical, orthopedic and interventional procedures that benefit from real-time surgical image guidance, such as decompression lumbar laminectomy, microdiscectomy, embolization of spinal malformations or tumors, vertebroplasty, and Kyphoplasty. NeuroLogica also manufactures CereTom®, the first small bore, portable CT scanner designed for the head and neck, which can easily be integrated into these joint OR solutions.
STERIS will deliver custom-designed high-definition integrated surgical suites featuring: LED surgical lighting and visualization systems; Harmony iQ™ advanced integration technology; OR equipment management systems; and surgical imaging tables. In addition, STERIS’s room planning services, including its three-dimensional Room Builder software and project design management expertise, will allow the two companies to design and seamlessly integrate their technologies for their clinical partners.
“The role of imaging in the surgical theater is to satisfy advanced care directives focused on improving outcomes and efficiency,” said Robert Popilock, senior manager of marketing and strategy for STERIS. “The STERIS-NeuroLogica relationship offers healthcare providers the ability to meet these directives while enhancing their operational flexibility and affordability. This adds significant value to the equation.”
About NeuroLogica Corporation
Located in Danvers, Massachusetts, NeuroLogica Corp (www.neurologica.com) specializes in the design and manufacture of cutting edge imaging equipment that is easy to use and brings the power of imaging to the patient. NeuroLogica`s BodyTom® CT and CereTom® CT are FDA registered and the quality system is certified to ISO 13485:2003 and ISO 9001:2008 with Canadian Medical Device Amendments. NeuroLogica`s BodyTom® CT and CereTom® CT are CE marked (European Conformity) for distribution in the European Union and European Economic Area.
About STERIS Corporation
STERIS Corporation is a leading provider of infection prevention and surgical products and services, focused primarily on critical healthcare, pharmaceutical and research markets around the world. The Company supplies a broad array of equipment, consumable and service solutions that help assure productivity and quality. STERIS is listed on the New York Stock Exchange under the symbol STE. For more information, visit www.steris.com.
Source: NeuroLogica Corp
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.